The Beauty Health Company (NASDAQ:SKIN) Shares Sold by Luxor Capital Group LP

Luxor Capital Group LP cut its position in The Beauty Health Company (NASDAQ:SKIN) by 48.8% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,486,304 shares of the company’s stock after selling 3,327,163 shares during the period. Beauty Health makes up 0.5% of Luxor Capital Group LP’s holdings, making the stock its 17th largest position. Luxor Capital Group LP owned approximately 2.82% of Beauty Health worth $6,694,000 at the end of the most recent quarter.

Several other institutional investors have also recently modified their holdings of SKIN. Federated Hermes Inc. raised its stake in shares of Beauty Health by 349,616.0% during the 2nd quarter. Federated Hermes Inc. now owns 370,699 shares of the company’s stock valued at $712,000 after buying an additional 370,593 shares during the last quarter. Sierra Summit Advisors LLC acquired a new stake in shares of Beauty Health during the 4th quarter worth approximately $856,000. Mirae Asset Global Investments Co. Ltd. acquired a new stake in shares of Beauty Health during the 1st quarter worth approximately $200,000. Russell Investments Group Ltd. purchased a new position in shares of Beauty Health during the 1st quarter valued at approximately $279,000. Finally, Caprock Group LLC purchased a new stake in Beauty Health during the second quarter worth $38,000. 93.26% of the stock is currently owned by hedge funds and other institutional investors.

Beauty Health Trading Up 3.8 %

Shares of SKIN stock opened at $1.37 on Friday. The Beauty Health Company has a fifty-two week low of $0.91 and a fifty-two week high of $6.25. The firm has a market capitalization of $169.91 million, a P/E ratio of -1.96 and a beta of 0.95. The stock’s fifty day moving average is $1.57 and its two-hundred day moving average is $2.42. The company has a debt-to-equity ratio of 7.96, a quick ratio of 5.47 and a current ratio of 6.49.

Beauty Health (NASDAQ:SKIN) last posted its quarterly earnings results on Thursday, August 8th. The company reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.05). Beauty Health had a negative return on equity of 4.57% and a negative net margin of 22.86%. The business had revenue of $90.60 million for the quarter, compared to analyst estimates of $98.46 million. Research analysts expect that The Beauty Health Company will post -0.2 earnings per share for the current fiscal year.

Insider Transactions at Beauty Health

In related news, Chairman Brent L. Saunders purchased 40,450 shares of the company’s stock in a transaction dated Monday, August 12th. The stock was acquired at an average cost of $1.08 per share, for a total transaction of $43,686.00. Following the completion of the transaction, the chairman now directly owns 5,921,769 shares of the company’s stock, valued at $6,395,510.52. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 41.00% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have weighed in on SKIN shares. Canaccord Genuity Group cut their price objective on shares of Beauty Health from $2.00 to $1.25 and set a “hold” rating for the company in a report on Monday, August 12th. Stifel Nicolaus dropped their price objective on Beauty Health from $4.00 to $2.00 and set a “hold” rating on the stock in a report on Friday, July 26th. Finally, Piper Sandler reaffirmed an “underweight” rating and set a $1.00 target price (down from $1.50) on shares of Beauty Health in a research note on Friday, August 9th. Three analysts have rated the stock with a sell rating, seven have assigned a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $2.46.

Beauty Health Company Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.